sevoflurane has been researched along with Necrobiosis Lipoidica in 1 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Necrobiosis Lipoidica: A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quintana-Castanedo, L | 1 |
| Recarte-Marín, L | 1 |
| Pérez-Jerónimo, L | 1 |
| Conde-Montero, E | 1 |
| de la Cueva-Dobao, P | 1 |
1 other study available for sevoflurane and Necrobiosis Lipoidica
| Article | Year |
|---|---|
Ulcerative necrobiosis lipoidica diabeticorum successfully treated with topical sevoflurane and punch grafting.
Topics: Administration, Topical; Humans; Necrobiosis Lipoidica; Platelet Aggregation Inhibitors; Sevoflurane | 2019 |